Scott Schell, PhD, MD, MBA is a healthcare futurist and precision medicine expert. His clinical experience is in surgical oncology, with basic-science research expertise in immunology and molecular genetics. A serial entrepreneur with 5 successful startups, and collaboration with dozens of other pharma, biomedical, device, and health tech companies. In addition to serving part-time as a Managing Partner and CMO in a private equity firm, he currently has a global consulting portfolio in population health, precision medicine, and application of AI to chronic and complex disease management